Omkar Speciality Chemicals files Patent application for precursor of latest Hepatitis C Drug

03 Jun 2015 Evaluate

Omkar Speciality Chemicals has filed one more application for the grant of Patent for preparing 4-Bromo-Ortho-Phenylene-Diamine, a key precursor for making of the drug namely Ledipasvir. Ledipasvir is a drug for the treatment of Hepatitis C.

Omkar Speciality Chemicals (including its wholly owned subsidiaries) has 9 Units in the State of Maharashtra, India (5 Units in Badlapur, Dist: Thane, 3 Units in Chiplun, Dist: Ratnagiri and 1 Unit in Mahad, Dist: Raigad) with a total volumetric installed capacity of 4920 MTPA.

Omkar SpecialityChem Share Price

5.71 -0.29 (-4.83%)
31-Dec-2025 10:45 View Price Chart
Peers
Company Name CMP
BASF India 3921.05
Tata Chemicals 766.70
SRF 3074.20
Pidilite Inds. 1463.40
Deepak Nitrite 1740.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×